Hyperpigmentation and Melasma

Causes, the Efficacy of Cosmelan Treatment

Authors

  • Gulnoza Kambarova Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

DOI:

https://doi.org/10.48112/acmr.v2i2.16

Keywords:

Cosmetology, Dermatology,, Post-Inflammatory Hyperpigmentation, Hyperpigmentation, Melisma

Abstract

Abstract Views: 137

hyperpigmentation is a frequent complaint, making up about 8.5% of all calls to dermatologists. They can be congenital, with different types of inheritance or acquired due to external factors, systemic diseases. This article will focus on acquired hyperpigmentation associated with elevated melanin levels. Particularly it should be emphasized aspects of therapy, with particular attention to melasma, post-inflammatory hyperpigmentation, periorbital pigmentation. Within a week, the appearance of the treated skin is noticeably improved. Skin type has a big influence on the effect of the treatment. People with skin phototype IV and V (dark skin) may notice that the effect will start faster because after 8-10 days. People with phototype I and II notice the disappearance of spots from 8 to 21 days. The overall effect of Cosmelan treatment should be up to 30 days. If we approach the correction of pigment formation from these positions, it becomes obvious that the effect in the skin should be as complex, soft and gentle as possible. Otherwise, there is a risk of getting not only a local reaction opposite to the desired one, but also harm the patient, aggravating the existing cosmetic defect and social psychological maladjustment of the personality.

References

Rendon, Marta, Berneburg, Mark, Arellano, Ivonne & Picardo, Mauro . 2006. Treatment of melasma. J Am Acad Dermatol. 54(5):272–281.

Grimes, P E . 1995. Melasma: etiologic and therapeutic considerations. Arch Dermatol. 131:1453–1460.

Ogbechie-Godec, Oluwatobi A. & Elbuluk, Nada . 2017. Melasma: an Up-to-Date Comprehensive Review. Dermatology and Therapy. Springer Science and Business Media LLC 7:305–318 https://dx.doi.org/10.1007/s13555-017-0194-1

Passeron, Thierry & Picardo, Mauro . 2018. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 31(4):461–465.

McKesey, Jacqueline, Tovar-Garza, Andrea & Pandya, Amit G. . 2020. Melasma Treatment: An Evidence-Based Review. Am J Clin Dermatol. 21:173–225.

Trivedi, M.K., Yang, F.C. & Cho, B.K. . 2017. A review of laser and light therapy in melasma. Int J Womens Dermatol. 3:11–20.

Kwon, S H, Na, J I, Choi, J Y & Park, K C . 2019. Melasma: Updates and perspectives. Experimental dermatology. Exp Dermatol. 28:704–712.

Taraz, Mohammad, Niknam, Somayeh & Ehsani, Amir Houshang . 2017. Tranexamic acid in treatment of melasma: A comprehensive review of clinical studies. Dermatol Ther. 30:12465.

Espósito, Ana Cláudia Cavalcante, Brianezi, Gabrielli, Souza, Nathalia Pereira de, Santos, Daniela Carvalho, Miot, Luciane Donida Bartoli & Miot, Hélio Amante . 2020. Ultrastructural characterization of damage in the basement membrane of facial melasma. Arch Dermatol Res. 312:223–227.

Published

2021-06-30

How to Cite

Kambarova, G. (2021). Hyperpigmentation and Melasma: Causes, the Efficacy of Cosmelan Treatment. Advances in Clinical Medical Research, 2(2), 05–08. https://doi.org/10.48112/acmr.v2i2.16